Otrinol | Excipients | Inactive | Generic | Formulation | PharmaCompass.com

Please Wait

Applying Filters...

Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector April 2025: Merck KGaA buys SpringWorks for US$ 3.9 bn; Swiss giants lead pharma migration to US soil

Stock Recap
#PipelineProspector

Otrinol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 25 USDMF, 10 CEP/COS, 1 JDMF, 3 EU WC, 6 KDMF, 12 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

312 FDF Dossiers, 112 FDA Orange Book, 3 Europe, 114 Canada, 50 South Africa, 33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - 8MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 240MG, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG, TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 9 Rochem International Inc, 22 SPI Pharma, 15 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 9 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 15 Actylis, 4 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 38 BASF, 1 Bioplus Life Sciences, 2 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 10 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 37 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

122 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 48 Direct Compression, 48 Disintegrants & Superdisintegrants, 46 Thickeners and Stabilizers, 41 Controlled & Modified Release, 37 Taste Masking, 37 Granulation, 36 Solubilizers, 34 Film Formers & Plasticizers, 33 Topical, 29 Lubricants & Glidants, 28 Parenteral, 25 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 11 Rheology Modifiers, 10 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 31 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

25 APIs

25 APIs

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

$ Xls

Filters

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 240MG

SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG

SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG

CAPSULE;ORAL - 8MG;60MG

TABLET;ORAL - 2MG;200MG;30MG

TABLET;ORAL - 200MG;30MG

X

Contact us
to update this info